The wide-ranging biological effects of GLP-1 RAs have further prompted investigation into other conditions, including Alzheimer’s disease (AD), where their impact appears favorable, although the current evidence remains preliminary [85]. This evidence concerns the gene GCG and Alzheimer disease.